Nigerian Representatives Of Overseas Pharmaceutical Manufacturers 
pinMAN CENTER, 5, Eleruwa Street, WEMABOD Estate, off Ajao Avenue, off Adeniyi Jones Avenue, Ikeja, Lagos
phone-iconE-mail:adminofficer@niropharm.org GSM: 07046435682

NIROPHARM Exco at the Seminar on "Ease of doing business in the Pharma Sector"
Customs, NAFDAC and others brought together on "The ease of doing business in Pharma Industry"
NIROPHARM Exco visits Hon Minister for Health

NIROPHARM'S INPUT TO NDDC  

  • Address fears/concerns of practitioners.
  • Creating level playing field for all importers and manufacturers.
  • Have the desired end in mind.
  • Industry needs to work with government towards implementation of a workable solution.
  • NDDC must carry all products registered with NAFDAC.
  • Funding/intervention fund for the distribution chain is imperative.


Read More

Niropharm is a body dedicated to the promotion of good pharmaceutical marketing practice and policy on behalf of it's members. Join

Minutes of Niropharm Breakfast Meetings

Breakfast Meeting

Minutes of CEO's Forum Meetings

CEO's Forum Meetings

Minutes of Niropharm General meetings

General Meeting Minutes

Pictures taken at various events and activities

Events Photo Album

HIV injectionEvery year, some 25 million people — one in ten of them children — die in serious pain that could have been alleviated with morphine at just a few cents per dose, researchers said Friday.  This represents nearly half of all deaths globally each year, they reported in The Lancet medical journal, warning of a “global pain crisis.” Morphine is hard to obtain in some countries and  virtually unobtainable in others. Mexico meets 36% of its need, China meets 16%, India 4% and Nigeria 0.2%. In some of the world’s poorest countries, such as Haiti, Afghanistan and many countries in Africa, oral morphine in palliative care is virtually non-existent.

The vast majority of people denied pain relief lived in low- and middle-income countries, which received less than four percent of the 299 tonnes of oral morphine distributed around the world, said the team. On the other side of the spectrum, abuse of opioid-based pain-killers was common in some rich nations, nowhere more so than the United States. “The pain gap is a double-edged sword with too little access to inexpensive opioids for poor nations and misuse by rich ones,” said study co-author Julio Frenk of the University of Miami.
Opioids are drugs that include codeine and morphine for pain relief, but also heroin. Not only was morphine harder to find in poor countries, it was also more expensive — at about 16 US cents for 10 milligrammes compared to three cents in rich nations, the report said. “We estimate that the cost of meeting the global shortfall of about 48.5 metric tonnes of morphine-equivalent opioids is about $145 million (122 million euros) per year if all countries had access to the lowest retail prices paid by some high-income countries,” the team wrote.
This was “a fraction of the cost” of running a medium-sized American hospital, and “a pittance” compared to the estimated $100 billion a year spent on the war on recreational drugs, said Frenk’s colleague Felicia Knaul.

– Children dying in pain –“The biggest shame is children in low-income countries dying in pain which could be eliminated for $1 million a year,” she said.
Cost was not the only problem, the team noted. “Failure of health systems in poor countries is a major reason that patients need palliative care in the first place,” World Bank president Jim Yong Kim said in a statement. “More than 90 percent of these child deaths are from avoidable causes.” The report was compiled by experts analysing the need for palliative care due to 20 life-threatening diseases such as HIV, cancer, heart disease, premature birth, tuberculosis, haemorrhagic fevers, lung and liver diseases, malnutrition, dementia, and trauma injuries.
Of the 172 countries studied, 25 had essentially no morphine, while a further 15 had enough to meet less than one percent of pain relief requirements. A hundred countries could meet the standard pain relief needs of less than a third of patients, the study found. “This global pain crisis can be remedied quickly and effectively,” said Knaul. “We have the right tools and knowledge and the cost of the solution is minimal. “Denying this intervention is a moral failing, especially for children and patients at the end of life.” Another 35 million sick people who did not die also had no access to morphine to relieve serious pain in 2015, the report added.

Source: punch
President of the Senate, Dr. Abubakar Bukola Saraki, has pledged the commitment of the 8th Senate to work with relevant agencies like the Pharmaceutical Society of Nigeria (PSN) to curb increasing incidence of drug abuse in the country. Saraki, according to a statement by his Special Assistant on Print Media, Chuks Okocha, spoke when the leadership of the PSN visited

Niropharm visits Hon Minister for Health

IMG 20160308 WA001

Mr. Soremekun Olufemi (Vice President, NIROPHARM and MD/CEO BIOFEM Pharmaceutical Nig Ltd.), Mr. Ijimakin Ola (Member, NIROPHARM and General Manager Marketing, Fidson Healthcare Plc.), Mr. Oyelohunnu Ibukun (Member, NIROPHARM), Prof. Isaac Folorunso Adewole (Minister, Fedral Ministry of Health), Mr. Asuni Lekan (President, NIROPHARM and MD. GlaxoSmithKline Pharmaceutical Nig. Ltd.), Mr. Addae Herman (Member, NIROPHARM and Country Manager, Roche Products Ltd.), Mr. Ogunjimi Sammy (Treasurer, NIROPHARM and MD. Codix Pharma Ltd.)

Upcoming Events

1



General Meeting
Holds every 2nd Tuesday of the Month at Opic Plaza

2Networking Dinner
Details to be provided very soon to members.
The objectives of the recent meeting with the Hon Minister, Federal Ministry of Health, Prof. Isaac Folorunso Adewole were as follows;
  1. Congratulate the Hon Minister on his appointment
  2. Shared with the Hon Minister of Health NIROPHARM’s position on improving access to medicines in Nigeria.
  3. The Hon Minister expressed satisfaction with our visit and promise to share our position with the relevant stakeholders in the ministry for consideration and appropriate action.
NIROPHARM works to promote good pharmaceutical marketing practice, good pharmaceutical manufacturing practice, distribution of quality pharmaceuticals and advocating at various levels for the making and establishment of policies and lawas that would greatly benefot the nigerian citizen and  healhcare stakeholders in the pharmaceutical industry.
As part of it's effort, NIROPHARM organizes seminars and workshops aimed at providing useful managemnt and business skills, business information and opportunities for growth and increased productivity to members and interested stakeholders.

Member Companies

alpha.pngassene.jpgastrazenica.pngbiofem.pngbolar.pngchanmedi.pngchoregex.jpgcodix.jpgemzor.jpgetherapeutics.jpgfidson.jpggrace_drugs_healthcare.jpggsk.jpgkorlyns.jpgmay-and-baker.jpgmedheights.jpgmegawecare.jpgnovartis.jpgnovonordisk.jpgocculus.jpgrealsgroup.pngtaylek.gifalpha.pngassene.jpgastrazenica.pngbiofem.pngbolar.pngchanmedi.pngchoregex.jpgcodix.jpgemzor.jpgetherapeutics.jpgfidson.jpggrace_drugs_healthcare.jpggsk.jpgkorlyns.jpgmay-and-baker.jpgmedheights.jpgmegawecare.jpgnovartis.jpgnovonordisk.jpgocculus.jpgrealsgroup.pngtaylek.gif

We are located at 5, Eleruwa Street, WEMABOD Estate, off Ajao Avenue, off Adeniyi Jones Avenue, Ikeja.

Want to be a member of NIROPHARM? arrow
© 2015 NIROPHARM. All rights reserved | Designed and Hosted by Tishri InfoTech Nig Ltd